SCHEMBL28937124

SCHEMBL28937124

COC(=O)c1cccc(NC(=O)c2ccc(F)cc2F)n1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1F P30939 4/20 0.61
MAPT P10636 1/20 0.55
RXFP1 Q9HBX9 1/20 0.49
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
TP53 P04637 3/20 0.46
NPC1 O15118 2/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2C19 P33261 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 1/20 0.45
CHRM5 P08912 1/20 0.44
DRD5 P21918 1/20 0.44
HTR1D P28221 1/20 0.44
HTR1E P28566 1/20 0.44
HTR7 P34969 1/20 0.44
OPRK1 P41145 1/20 0.44
TMEM97 Q5BJF2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28937129 0.88 HTR1F (0.62) HTR1FMAPTRXFP1MEN1KMT2A
SCHEMBL28937149 0.85 HTR1F (0.61) HTR1FMEN1KMT2ATP53NPC1
SCHEMBL23702725 0.84 HTR1F (0.60) HTR1FMAPTMEN1KMT2ATP53
SCHEMBL28937134 0.81 MAPT (0.64) HTR1FMAPTRXFP1MEN1KMT2A
SCHEMBL1197324 0.80 HTR1F (0.56) HTR1FMEN1KMT2ATP53NPC1
SCHEMBL28808156 0.80 HTR1F (0.56) HTR1FMEN1KMT2ATP53NPC1
SCHEMBL28963589 0.79 MAPT (0.61) HTR1FMAPTTP53NPC1CYP1A2
SCHEMBL30908910 0.76 HTR1F (0.77) HTR1FCHRM5DRD5HTR1DHTR1E
SCHEMBL21770996 0.76 HTR1F (1.00) HTR1FTP53CHRM5DRD5HTR1D
SCHEMBL2537931 0.76 HTR1F (0.77) HTR1FCHRM5DRD5HTR1DHTR1E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110272425-B Pyridyloxyl octahydropyrrolo [3,4-c ] pyrrole derivatives and uses thereof 广东东阳光药业有限公司 2022-11-04 CN disclosed